|
|
 |
| |
|
|
 |
| |
Chairman |
|
Sheikh Yousuf Jamjoom |
| |
|
|
|
| |
Managing Director |
|
Mr. Noor Sheriff |
| |
|
|
|
| |
Joint Managing Director |
|
Mr. Mahmoud Y. Jamjoom |
| |
|
|
|
| |
Corporate Headquarter |
|
Jeddah, Saudi Arabia |
| |
|
|
|
| |
Jamjoom Pharma Web Site |
|
http://www.jamjoompharma.com |
| |
|
|
|
| |
Jamjoom Pharma outside KSA |
|
Distributors Network |
| |
Corporate Headquarters |
|
Jeddah, Saudi Arabia |
| |
|
|
|
| |
Area of Product Focus |
|
- Ophthalmology
- Derma
- Infection
- Gastrointestinal
- Cardiovascular
- General Medicine |
| |
|
| |
|
|
|
| |
Products Availability |
|
Saudi Arabia and 15 other countries in the Middle East and Africa area. |
| |
|
|
|
| |
Products |
|
Over 70 different Products |
| |
|
|
|
| |
Key Products |
|
| Aciloc ™ |
| Amvasc ™ |
Azi-Once ™ |
Ciproxen ™ |
Duracan ™ |
Elica ™ |
Elicasal ™ |
Fixit ™ |
Hyfresh ™ |
Loxtra ™ |
Momenta ™ |
Tymer ™ |
Xolamol ™ |
|
|
| | |
|
|
|
